Daxin Pharmaceuticals is an API manufacturer. Customs aggregates show $103K of exports covering 16 molecules to 1 destination in 2023.
| Molecule | Regulators | Docs |
|---|---|---|
| Tobramycin | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2023 | Not reported | $103K | 1 |
| 2022 | Not reported | $174K | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Daxin Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free